PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsCelera claims human genome success

BioNews

Celera claims human genome success

Published 9 June 2009 posted in News and appears in BioNews 53

Author

BioNews

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

US firm Celera Genomics claimed last week that it has finished sequencing 99 per cent of the human genome, and is now putting the information together in a meaningful order. The announcement follows a statement last week from the publicly-funded Human Genome Project, which aims to publish a rough draft...

US firm Celera Genomics claimed last week that it has finished sequencing 99 per cent of the human genome, and is now putting the information together in a meaningful order. The announcement follows a statement last week from the publicly-funded Human Genome Project, which aims to publish a rough draft of the genome by the end of June.


Craig Venter, head of Celera, said that the company would now turn its computational power to the task of ordering the genome. Shares in Celera rose by 19 per cent following the statement, which prompted criticism from the firm's public sector rivals.


Tim Hubbard, head of human genome sequencing at the Sanger Centre in Cambridge, suspected Venter's announcement was aimed more at his shareholders than scientists. 'He's got fragments of DNA sequences but has not yet assembled them into anything meaningful' Dr Hubbard told the Independent on Sunday. He likened Celera's data to a shredded copy of the Encyclopaedia Britannica: 'You might be able to read fragments of it but it won't mean very much' he added. John Sulston, head of the Sanger Centre, told the Guardian that the announcement meant little as long as Celera was keeping its data a commercial.


Dr Venter, in a written testimony for a Congressional hearing held last week says that from its formation, Celera's goal has been to produce a high-quality human genome sequence that will stand the test of time. He described the public consortium's data as 'an unordered collection of over 500,000 fragments' that is 'nowhere close to being done'.


Although the competition between the public and private bodies sequencing the genome is being widely perceived as a race, Dr Sulston argues the two sides are pursuing different goals. 'They want to make a profit' he says of Celera, adding 'We want to make the data publicly available'.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
18 January 2010 • 1 minute read

India sequences its first human genome

by Dr Vivienne Raper

India has sequenced its first full human genome becoming the sixth country to do so, according to the Indian Government. The genome of a 52-year-old man from Jharkhand, eastern India, was reportedly sequenced by a top Indian science research body at a cost of $30,000. The breakthrough will help pharmaceutical companies develop drugs better suited to Indian physiology, according to India's Council of Scientific and Industrial Research (CSIR)....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Selected biotech news

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856